Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Internal Medicine (Tokyo, Japan)|September 16, 2015
Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis TreatmentNobuyuki Horita, Naoki Miyazawa, Takashi Yoshiyama, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2022
Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trialsYu Fujiwara, Nobuyuki Horita, Matthew Harrington, et al.
Clinical Lung Cancer|May 14, 2013
Preoperative chemotherapy is effective for stage III resectable non--small-cell lung cancer: metaanalysis of 16 trialsNobuyuki Horita, Naoki Miyazawa, Satoshi Morita, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 30, 2021
ABO blood group as a risk factor for tuberculosis: A network meta-analysisHao Chen, Nobuyuki Horita, Hiromi Matsumoto, et al.
Respiratory Investigation|July 14, 2026
The JRS guideline for the management of chronic obstructive pulmonary disease 7th edition 2026Hisatoshi Sugiura, Naoya Fujino, Yoko Shibata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 15, 2016
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung CarcinomaKentaro Nakashima, Nobuyuki Horita, Kenjiro Nagai, et al.
COPD|July 27, 2013
Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego Shortness of Breath QuestionnaireNobuyuki Horita, Naoki Miyazawa, Satoshi Morita, et al.
The Cochrane Database of Systematic Reviews|February 11, 2017
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)Nobuyuki Horita, Atsushi Goto, Yuji Shibata, et al.
Respirology (Carlton, Vic.)|August 6, 2013
Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysisNobuyuki Horita, Naoki Miyazawa, Ryota Kojima, et al.
Respiratory Research|April 9, 2014
Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary diseaseNobuyuki Horita, Naoki Miyazawa, Satoshi Morita, et al.
Pageof 22